Overexpression of glucose transporter-1 (GLUT-1) predicts poor prognosis in epithelial ovarian cancer

Hanbyoul Cho, You Sun Lee, Julie Kim, Joon Yong Chung, Jae Hoon Kim

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Illumina microarray was used to identify differentially expressed genes in three epithelial ovarian cancer (EOC) cells. To validate the microarray data, mRNA and protein level of glucose transporter-1 (GLUT-1) was examined. GLUT-1 had an EOC/normal cells ratio of 5.51 based on microarray. Real-time PCR and immunohistochemistry demonstrated that GLUT-1 expression was significantly increased in EOC (p = .029 and p < .001, respectively). On survival analysis, GLUT-1 overexpression (HR = 4.80, p = .027) and lymph node metastases (HR = 8.35, p = .016) conferred a significantly worse overall survival. In conclusion, GLUT-1 expression is remarkably upregulated in EOC and predicts a poor overall survival.

Original languageEnglish
Pages (from-to)607-615
Number of pages9
JournalCancer Investigation
Volume31
Issue number9
DOIs
Publication statusPublished - 2013 Nov 1

Fingerprint

Facilitative Glucose Transport Proteins
Survival Analysis
Real-Time Polymerase Chain Reaction
Lymph Nodes
Immunohistochemistry
Ovarian epithelial cancer
Neoplasm Metastasis
Messenger RNA
Genes
Proteins

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Cho, Hanbyoul ; Lee, You Sun ; Kim, Julie ; Chung, Joon Yong ; Kim, Jae Hoon. / Overexpression of glucose transporter-1 (GLUT-1) predicts poor prognosis in epithelial ovarian cancer. In: Cancer Investigation. 2013 ; Vol. 31, No. 9. pp. 607-615.
@article{4e44bf48bb504522b1dc3faf0ebd3671,
title = "Overexpression of glucose transporter-1 (GLUT-1) predicts poor prognosis in epithelial ovarian cancer",
abstract = "Illumina microarray was used to identify differentially expressed genes in three epithelial ovarian cancer (EOC) cells. To validate the microarray data, mRNA and protein level of glucose transporter-1 (GLUT-1) was examined. GLUT-1 had an EOC/normal cells ratio of 5.51 based on microarray. Real-time PCR and immunohistochemistry demonstrated that GLUT-1 expression was significantly increased in EOC (p = .029 and p < .001, respectively). On survival analysis, GLUT-1 overexpression (HR = 4.80, p = .027) and lymph node metastases (HR = 8.35, p = .016) conferred a significantly worse overall survival. In conclusion, GLUT-1 expression is remarkably upregulated in EOC and predicts a poor overall survival.",
author = "Hanbyoul Cho and Lee, {You Sun} and Julie Kim and Chung, {Joon Yong} and Kim, {Jae Hoon}",
year = "2013",
month = "11",
day = "1",
doi = "10.3109/07357907.2013.849722",
language = "English",
volume = "31",
pages = "607--615",
journal = "Cancer Investigation",
issn = "0735-7907",
publisher = "Informa Healthcare",
number = "9",

}

Overexpression of glucose transporter-1 (GLUT-1) predicts poor prognosis in epithelial ovarian cancer. / Cho, Hanbyoul; Lee, You Sun; Kim, Julie; Chung, Joon Yong; Kim, Jae Hoon.

In: Cancer Investigation, Vol. 31, No. 9, 01.11.2013, p. 607-615.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Overexpression of glucose transporter-1 (GLUT-1) predicts poor prognosis in epithelial ovarian cancer

AU - Cho, Hanbyoul

AU - Lee, You Sun

AU - Kim, Julie

AU - Chung, Joon Yong

AU - Kim, Jae Hoon

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Illumina microarray was used to identify differentially expressed genes in three epithelial ovarian cancer (EOC) cells. To validate the microarray data, mRNA and protein level of glucose transporter-1 (GLUT-1) was examined. GLUT-1 had an EOC/normal cells ratio of 5.51 based on microarray. Real-time PCR and immunohistochemistry demonstrated that GLUT-1 expression was significantly increased in EOC (p = .029 and p < .001, respectively). On survival analysis, GLUT-1 overexpression (HR = 4.80, p = .027) and lymph node metastases (HR = 8.35, p = .016) conferred a significantly worse overall survival. In conclusion, GLUT-1 expression is remarkably upregulated in EOC and predicts a poor overall survival.

AB - Illumina microarray was used to identify differentially expressed genes in three epithelial ovarian cancer (EOC) cells. To validate the microarray data, mRNA and protein level of glucose transporter-1 (GLUT-1) was examined. GLUT-1 had an EOC/normal cells ratio of 5.51 based on microarray. Real-time PCR and immunohistochemistry demonstrated that GLUT-1 expression was significantly increased in EOC (p = .029 and p < .001, respectively). On survival analysis, GLUT-1 overexpression (HR = 4.80, p = .027) and lymph node metastases (HR = 8.35, p = .016) conferred a significantly worse overall survival. In conclusion, GLUT-1 expression is remarkably upregulated in EOC and predicts a poor overall survival.

UR - http://www.scopus.com/inward/record.url?scp=84887218455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887218455&partnerID=8YFLogxK

U2 - 10.3109/07357907.2013.849722

DO - 10.3109/07357907.2013.849722

M3 - Article

C2 - 24164300

AN - SCOPUS:84887218455

VL - 31

SP - 607

EP - 615

JO - Cancer Investigation

JF - Cancer Investigation

SN - 0735-7907

IS - 9

ER -